EHC
Income statement / Annual
Last year (2024), Encompass Health Corporation's total revenue was $5.37 B,
an increase of 11.91% from the previous year.
In 2024, Encompass Health Corporation's net income was $455.70 M.
See Encompass Health Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$5.37 B |
$4.80 B |
$4.35 B |
$5.12 B |
$4.64 B |
$4.61 B |
$4.28 B |
$3.92 B |
$3.65 B |
$3.12 B |
| Cost of Revenue |
$2.90 B
|
$3.87 B
|
$202.10 M
|
$209.30 M
|
$200.50 M
|
$167.90 M
|
$158.70 M
|
$149.30 M
|
$140.00 M
|
$128.70 M
|
| Gross Profit |
$2.47 B
|
$933.50 M
|
$4.15 B
|
$4.91 B
|
$4.44 B
|
$4.44 B
|
$4.12 B
|
$3.77 B
|
$3.51 B
|
$2.99 B
|
| Gross Profit Ratio |
0.46
|
0.19
|
0.95
|
0.96
|
0.96
|
0.96
|
0.96
|
0.96
|
0.96
|
0.96
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$209.20 M
|
$201.70 M
|
$2.60 B
|
$3.16 B
|
$2.92 B
|
$2.90 B
|
$2.65 B
|
$2.40 B
|
$2.19 B
|
$1.86 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$209.20 M
|
$201.70 M
|
$2.60 B
|
$3.16 B
|
$2.92 B
|
$2.90 B
|
$2.65 B
|
$2.40 B
|
$2.19 B
|
$1.86 B
|
| Other Expenses |
$1.40 B
|
$0.00
|
$914.00 M
|
$941.80 M
|
$877.40 M
|
$842.30 M
|
$2.20 M
|
$4.10 M
|
$2.90 M
|
$5.50 M
|
| Operating Expenses |
$1.61 B
|
$693.90 M
|
$3.52 B
|
$4.11 B
|
$3.80 B
|
$3.74 B
|
$3.44 B
|
$3.12 B
|
$2.86 B
|
$2.43 B
|
| Cost And Expenses |
$4.51 B
|
$4.07 B
|
$3.72 B
|
$4.32 B
|
$4.00 B
|
$3.91 B
|
$3.60 B
|
$3.27 B
|
$3.00 B
|
$2.56 B
|
| Interest Income |
$0.00
|
$0.00
|
$175.70 M
|
$164.30 M
|
$183.70 M
|
$159.70 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$137.40 M
|
$143.50 M
|
$175.70 M
|
$164.60 M
|
$184.20 M
|
$159.70 M
|
$147.30 M
|
$154.40 M
|
$172.10 M
|
$142.90 M
|
| Depreciation & Amortization |
$299.60 M
|
$273.90 M
|
$243.60 M
|
$219.60 M
|
$243.00 M
|
$218.70 M
|
$199.70 M
|
$183.80 M
|
$172.60 M
|
$139.70 M
|
| EBITDA |
$1.19 B |
$1.02 B |
$873.80 M |
$879.00 M |
$815.20 M |
$911.20 M |
$881.30 M |
$833.20 M |
$823.80 M |
$709.20 M |
| EBITDA Ratio |
0.22
|
0.21
|
0.2
|
0.21
|
0.19
|
0.21
|
0.21
|
0.22
|
0.23
|
0.23
|
| Operating Income Ratio |
0.11
|
0.15
|
0.14
|
0.16
|
0.14
|
0.16
|
0.16
|
0.17
|
0.18
|
0.18
|
| Total Other Income/Expenses Net |
$150.20 M
|
-$124.60 M
|
-$1.09 B
|
-$969.90 M
|
$103.80 M
|
-$130.20 M
|
-$188.40 M
|
-$153.00 M
|
-$166.80 M
|
-$158.60 M
|
| Income Before Tax |
$749.60 M
|
$607.20 M
|
$450.80 M
|
$657.20 M
|
$472.60 M
|
$562.30 M
|
$493.20 M
|
$496.40 M
|
$482.00 M
|
$395.60 M
|
| Income Before Tax Ratio |
0.14
|
0.13
|
0.1
|
0.13
|
0.1
|
0.12
|
0.12
|
0.13
|
0.13
|
0.13
|
| Income Tax Expense |
$150.20 M
|
$132.20 M
|
$100.10 M
|
$139.60 M
|
$103.80 M
|
$115.90 M
|
$118.90 M
|
$160.60 M
|
$163.90 M
|
$141.90 M
|
| Net Income |
$455.70 M
|
$352.00 M
|
$271.00 M
|
$412.20 M
|
$284.20 M
|
$358.70 M
|
$292.30 M
|
$256.30 M
|
$247.60 M
|
$183.10 M
|
| Net Income Ratio |
0.08
|
0.07
|
0.06
|
0.08
|
0.06
|
0.08
|
0.07
|
0.07
|
0.07
|
0.06
|
| EPS |
4.56 |
3.54 |
2.72 |
4.15 |
2.87 |
3.65 |
2.99 |
2.73 |
2.77 |
2.02 |
| EPS Diluted |
4.46 |
3.47 |
2.7 |
4.11 |
2.85 |
3.61 |
2.93 |
2.69 |
2.59 |
1.91 |
| Weighted Average Shares Out |
$99.90 M
|
$99.50 M
|
$99.20 M
|
$99.00 M
|
$98.60 M
|
$98.00 M
|
$97.90 M
|
$93.70 M
|
$89.10 M
|
$89.40 M
|
| Weighted Average Shares Out Diluted |
$102.20 M
|
$101.30 M
|
$100.40 M
|
$100.20 M
|
$99.80 M
|
$99.40 M
|
$99.80 M
|
$99.30 M
|
$99.50 M
|
$101.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
